Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
出版年份 2018 全文链接
标题
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
作者
关键词
-
出版物
Cancers
Volume 10, Issue 8, Pages 248
出版商
MDPI AG
发表日期
2018-07-28
DOI
10.3390/cancers10080248
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
- (2018) E E Vokes et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase
- (2018) Dana M. Gwinn et al. CANCER CELL
- c-RAF Ablation Induces Regression of Advanced Kras/Trp 53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling
- (2018) Manuel Sanclemente et al. CANCER CELL
- PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth
- (2018) Mami Morita et al. CANCER CELL
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
- (2018) Michael K. Asiedu et al. CLINICAL CANCER RESEARCH
- Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing
- (2018) Charles Ricordel et al. Clinical Lung Cancer
- Spatial-Temporal Lineage Restrictions of Embryonic p63 + Progenitors Establish Distinct Stem Cell Pools in Adult Airways
- (2018) Ying Yang et al. DEVELOPMENTAL CELL
- Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
- (2018) Jason J. Luke et al. JOURNAL OF CLINICAL ONCOLOGY
- Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer
- (2018) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non–Small-Cell Lung Cancer
- (2018) Benjamin J. Solomon et al. JOURNAL OF CLINICAL ONCOLOGY
- Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study
- (2018) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non–Small-Cell Lung Cancer
- (2018) Yi-Long Wu et al. JOURNAL OF CLINICAL ONCOLOGY
- Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials
- (2018) D. Ross Camidge et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
- (2018) Hira Rizvi et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- (2018) Neal I. Lindeman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung
- (2018) Naoko Imanishi et al. JOURNAL OF SURGICAL ONCOLOGY
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- (2018) Neal I. Lindeman et al. Journal of Thoracic Oncology
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
- (2018) Marina Chiara Garassino et al. LANCET ONCOLOGY
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
- (2018) Fabio Conforti et al. LANCET ONCOLOGY
- Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer
- (2018) Kentaro Tanaka et al. LUNG CANCER
- SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
- (2018) Leila Dardaei et al. NATURE MEDICINE
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis
- (2018) Qibiao Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells
- (2018) Ahmad N. Nabhan et al. SCIENCE
- The Epithelial Sodium Channel (αENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors
- (2018) Min He et al. Translational Oncology
- Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients
- (2018) Cheng Wang et al. Nature Communications
- Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
- (2018) Julie George et al. Nature Communications
- Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts
- (2018) Benjamin J. Drapkin et al. Cancer Discovery
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- (2018) Ferdinandos Skoulidis et al. Cancer Discovery
- Regeneration of functional alveoli by adult human SOX9+ airway basal cell transplantation
- (2018) Qiwang Ma et al. Protein & Cell
- Classifying Non-Small Cell Lung Cancer by Status of Programmed Cell Death Ligand 1 and Tumor-Infiltrating Lymphocytes on Tumor Cells
- (2018) Shaohua Cui et al. Journal of Cancer
- The benefit and risk of nivolumab in non-small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized controlled trials
- (2018) Binghao Zhao et al. Cancer Medicine
- Immunotherapy in surgically resectable non-small cell lung cancer
- (2018) Dwight Owen et al. Journal of Thoracic Disease
- Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
- (2018) Chia-Chi Lin et al. Lancet Respiratory Medicine
- Treatment of Advanced Non–Small Cell Lung Cancer in 2018
- (2018) Deborah B. Doroshow et al. JAMA Oncology
- Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer
- (2018) Laura Mezquita et al. JAMA Oncology
- Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma
- (2018) Chee Khoon Lee et al. JAMA Oncology
- Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor
- (2018) William J. Zacharias et al. NATURE
- Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity
- (2017) Frances K. Turrell et al. GENES & DEVELOPMENT
- Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer
- (2017) Ramaswamy Govindan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)
- (2017) Solange Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer
- (2017) Reinhard Büttner et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
- (2017) Leora Horn et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
- (2017) Lucia Nogova et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study
- (2017) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2017) Nasser Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses
- (2017) Tony S.K. Mok et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokers
- (2017) Ha Youn Lee et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2 : CALGB 151111 (Alliance)
- (2017) Arnaud Augert et al. Journal of Thoracic Oncology
- OA05.01 Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer: Updated Survival Results from KEYNOTE-028
- (2017) Patrick Ott et al. Journal of Thoracic Oncology
- Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer
- (2017) Xiaomei Gong et al. Journal of Thoracic Oncology
- Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape
- (2017) Hawazin Faruki et al. Journal of Thoracic Oncology
- Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
- (2017) Toyoaki Hida et al. LANCET
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
- (2017) Matthew D Hellmann et al. LANCET ONCOLOGY
- Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
- (2017) Julie R Brahmer et al. LANCET ONCOLOGY
- Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
- (2017) Narek Shaverdian et al. LANCET ONCOLOGY
- Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
- (2017) Charles M Rudin et al. LANCET ONCOLOGY
- Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer
- (2017) Naomi Kobayashi-Watanabe et al. LUNG CANCER
- The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma
- (2017) Kazuki Takada et al. LUNG CANCER
- Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma
- (2017) Clare E. Weeden et al. MOLECULAR CANCER THERAPEUTICS
- Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398
- (2017) Jharna Datta et al. MOLECULAR CANCER THERAPEUTICS
- Integrative clinical genomics of metastatic cancer
- (2017) Dan R. Robinson et al. NATURE
- Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
- (2017) Jing Shan Lim et al. NATURE
- Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
- (2017) Rodrigo Romero et al. NATURE MEDICINE
- Isolation and 3D expansion of multipotent Sox9+ mouse lung progenitors
- (2017) Massimo Nichane et al. NATURE METHODS
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
- (2017) David P. Carbone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
- (2017) Solange Peters et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Krasmutant genetically engineered mouse models of human cancers are genomically heterogeneous
- (2017) Wei-Jen Chung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of epigenetics in lung cancer heterogeneity and clinical implication
- (2017) Nian Dong et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer
- (2017) Fidelis Andrea Flockerzi et al. VIRCHOWS ARCHIV
- Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer
- (2017) Sabina Berezowska et al. VIRCHOWS ARCHIV
- Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
- (2017) Haikuo Zhang et al. Nature Communications
- Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity
- (2017) Ian P. Winters et al. Nature Communications
- Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
- (2017) Emmet J. Jordan et al. Cancer Discovery
- Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism
- (2017) Claudia Fumarola et al. Oncotarget
- Role and regulation of Yap in KrasG12D-induced lung cancer
- (2017) Yaopan Mao et al. Oncotarget
- Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study
- (2017) Michaël Duruisseaux et al. Oncotarget
- Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer
- (2017) Fabian Doerr et al. Scientific Reports
- Incidence and mortality of lung cancer: global trends and association with socioeconomic status
- (2017) Martin C. S. Wong et al. Scientific Reports
- Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
- (2017) Massimo Moro et al. Scientific Reports
- Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients
- (2017) Mi-Sook Lee et al. Cancer Research and Treatment
- Prognostic value of PD-L1 expression in combination with CD8+ TILs density in patients with surgically resected non-small cell lung cancer
- (2017) Hui Yang et al. Cancer Medicine
- Comprehensive investigation of clinicopathologic features, oncogenic driver mutations and immunohistochemical markers in peripheral lung squamous cell carcinoma
- (2017) Yang Zhang et al. Journal of Thoracic Disease
- Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer
- (2017) Daiana D. Becker-Santos et al. EBioMedicine
- PD-L1 expression in lung adenosquamous carcinomas compared with the more common variants of non-small cell lung cancer
- (2017) Xiaohua Shi et al. Scientific Reports
- Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition
- (2017) Verena Tiran et al. Scientific Reports
- Clinical correlation of extensive-stage small-cell lung cancer genomics
- (2016) A. Dowlati et al. ANNALS OF ONCOLOGY
- Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer
- (2016) Michela Serresi et al. CANCER CELL
- SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin
- (2016) Giustina Ferone et al. CANCER CELL
- Squamous Cell Cancers: A Unified Perspective on Biology and Genetics
- (2016) G. Paolo Dotto et al. CANCER CELL
- Early Events in the Molecular Pathogenesis of Lung Cancer
- (2016) H. Kadara et al. Cancer Prevention Research
- Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
- (2016) Sarah K. Denny et al. CELL
- Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung
- (2016) Tomohiro Miyoshi et al. CLINICAL CANCER RESEARCH
- Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
- (2016) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy
- (2016) Takaaki Tokito et al. EUROPEAN JOURNAL OF CANCER
- Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
- (2016) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role forTERT,RB1,MEN1andKMT2D
- (2016) Michele Simbolo et al. JOURNAL OF PATHOLOGY
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
- (2016) Keunchil Park et al. LANCET ONCOLOGY
- Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
- (2016) Emma M. Kerr et al. NATURE
- Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
- (2016) Yong Jia et al. NATURE
- Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
- (2016) Joshua D Campbell et al. NATURE GENETICS
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape ofEGFR-,MYC-, andKras-driven genetically engineered mouse models of lung adenocarcinoma
- (2016) David G. McFadden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
- (2016) Nan Wu et al. Oncotarget
- Genetic alteration profiling of patients with resected squamous cell lung carcinomas
- (2016) Dan Tao et al. Oncotarget
- Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis
- (2016) Qingbao Li et al. Oncotarget
- PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
- (2016) Francesco Passiglia et al. Oncotarget
- SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
- (2016) Takuya Fukazawa et al. Scientific Reports
- Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods
- (2016) Xiaohua Shi et al. Scientific Reports
- Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
- (2016) Hong In Yoon et al. Cancer Research and Treatment
- Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
- (2016) Nadine S. Jahchan et al. Cell Reports
- Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
- (2016) Ekaterina A. Semenova et al. Cell Reports
- ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs
- (2016) Mark D. Borromeo et al. Cell Reports
- Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study
- (2016) Jianxin Shi et al. PLOS MEDICINE
- Rare SOX2 + Airway Progenitor Cells Generate KRT5 + Cells that Repopulate Damaged Alveolar Parenchyma following Influenza Virus Infection
- (2016) Samriddha Ray et al. Stem Cell Reports
- Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non–Small-Cell Lung Cancer
- (2016) Adrian G. Sacher et al. JAMA Oncology
- YAP Promotes Malignant Progression ofLkb1-Deficient Lung Adenocarcinoma through Downstream Regulation of Survivin
- (2015) Wenjing Zhang et al. CANCER RESEARCH
- Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib
- (2015) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- Lung Master Protocol (Lung-MAP)--A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
- (2015) R. S. Herbst et al. CLINICAL CANCER RESEARCH
- Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches
- (2015) A. Drilon et al. CLINICAL CANCER RESEARCH
- Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas
- (2015) Sehui Kim et al. EUROPEAN JOURNAL OF CANCER
- Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial
- (2015) Ariel Lopez-Chavez et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung cancer incidence and ambient air pollution in China: a spatial age–period cohort study 1990–2009
- (2015) Yuming Guo et al. LANCET
- Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
- (2015) Andrew B Sharabi et al. LANCET ONCOLOGY
- NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy
- (2015) C. Xu et al. MOLECULAR CANCER THERAPEUTICS
- Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis
- (2015) Maria Moksnes Bjaanaes et al. Molecular Oncology
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors
- (2015) Christine M. Fillmore et al. NATURE
- Telomere dysfunction causes alveolar stem cell failure
- (2015) Jonathan K. Alder et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
- (2015) Laura R. Saunders et al. Science Translational Medicine
- Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
- (2015) Evgeny Izumchenko et al. Nature Communications
- Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma
- (2015) Chenguang Li et al. Scientific Reports
- A New Mouse Avatar Model of Non-Small Cell Lung Cancer
- (2015) Maria Veronica Russo et al. Frontiers in Oncology
- Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer
- (2015) Xiao-Yang Wang et al. Oncotarget
- Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
- (2014) Chunxiao Xu et al. CANCER CELL
- The PRKCI and SOX2 Oncogenes Are Coamplified and Cooperate to Activate Hedgehog Signaling in Lung Squamous Cell Carcinoma
- (2014) Verline Justilien et al. CANCER CELL
- CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist
- (2014) S. Sarvi et al. CANCER RESEARCH
- Adaptive Responses to Dasatinib-Treated Lung Squamous Cell Cancer Cells Harboring DDR2 Mutations
- (2014) Y. Bai et al. CANCER RESEARCH
- Activin Upregulation by NF- B Is Required to Maintain Mesenchymal Features of Cancer Stem-like Cells in Non-Small Cell Lung Cancer
- (2014) J. J. Wamsley et al. CANCER RESEARCH
- Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing
- (2014) David G. McFadden et al. CELL
- Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
- (2014) Katherine A. Hoadley et al. CELL
- Dynamic Changes in Intracellular ROS Levels Regulate Airway Basal Stem Cell Homeostasis through Nrf2-Dependent Notch Signaling
- (2014) Manash K. Paul et al. Cell Stem Cell
- Patient-Derived Xenografts from Non-Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy
- (2014) H. W. Lee et al. CLINICAL CANCER RESEARCH
- Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome
- (2014) A. Karlsson et al. CLINICAL CANCER RESEARCH
- Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity
- (2014) C. Brambilla et al. CLINICAL CANCER RESEARCH
- Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non-Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway
- (2014) C. Shao et al. CLINICAL CANCER RESEARCH
- Lung development: orchestrating the generation and regeneration of a complex organ
- (2014) M. Herriges et al. DEVELOPMENT
- The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2
- (2014) Xia Xu et al. GENES & DEVELOPMENT
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Telomerase mutations in smokers with severe emphysema
- (2014) Susan E. Stanley et al. JOURNAL OF CLINICAL INVESTIGATION
- Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
- (2014) Xun Yuan et al. Journal of Hematology & Oncology
- Analysis of Major Known Driver Mutations and Prognosis in Resected Adenosquamous Lung Carcinomas
- (2014) Rui Wang et al. Journal of Thoracic Oncology
- Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint
- (2014) Matthew D Hellmann et al. LANCET ONCOLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Alveolar progenitor and stem cells in lung development, renewal and cancer
- (2014) Tushar J. Desai et al. NATURE
- p63+Krt5+ distal airway stem cells are essential for lung regeneration
- (2014) Wei Zuo et al. NATURE
- Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury
- (2014) Andrew E. Vaughan et al. NATURE
- The mutational landscapes of genetic and chemical models of Kras-driven lung cancer
- (2014) Peter M. K. Westcott et al. NATURE
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased SOX2 Gene Copy Number Is Associated with FGFR1 and PIK3CA Gene Gain in Non-Small Cell Lung Cancer and Predicts Improved Survival in Early Stage Disease
- (2014) Luca Toschi et al. PLoS One
- Genomic Characterisation of Small Cell Lung Cancer Patient-Derived Xenografts Generated from Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Specimens
- (2014) Tracy L. Leong et al. PLoS One
- ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
- (2014) A. Augustyn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma
- (2014) Kate D. Sutherland et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
- (2014) J. Zhang et al. SCIENCE
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- (2014) E. C. de Bruin et al. SCIENCE
- Activated Leukocyte Cell Adhesion Molecule (CD166): An “Inert” Cancer Stem Cell Marker for Non-Small Cell Lung Cancer?
- (2014) Michael Tachezy et al. STEM CELLS
- Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma
- (2014) haichuan hu et al. OncoTargets and Therapy
- YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression
- (2014) Yijun Gao et al. Nature Communications
- A paracrine network regulates the cross-talk between human lung stem cells and the stroma
- (2014) E. Josue Ruiz et al. Nature Communications
- Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
- (2014) Lynnette Fernandez-Cuesta et al. Nature Communications
- A Large-scale Cross-sectional Study of ALK Rearrangements and EGFR Mutations in Non-small-cell Lung Cancer in Chinese Han Population
- (2014) Shaodong Hong et al. Scientific Reports
- Sox2 Cooperates with Lkb1 Loss in a Mouse Model of Squamous Cell Lung Cancer
- (2014) Anandaroop Mukhopadhyay et al. Cell Reports
- Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps
- (2014) Marius Ilie et al. Cancer Medicine
- Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity
- (2013) D Wu et al. BRITISH JOURNAL OF CANCER
- The Pivotal Role of IKKα in the Development of Spontaneous Lung Squamous Cell Carcinomas
- (2013) Zuoxiang Xiao et al. CANCER CELL
- A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal
- (2013) Yanyan Zheng et al. CANCER CELL
- Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma
- (2013) R. G. Liao et al. CANCER RESEARCH
- Notch Pathway Activity Identifies Cells with Cancer Stem Cell-like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
- (2013) K. A. Hassan et al. CLINICAL CANCER RESEARCH
- Fgf10-positive cells represent a progenitor cell population during lung development and postnatally
- (2013) E. El Agha et al. DEVELOPMENT
- Type 2 alveolar cells are stem cells in adult lung
- (2013) Christina E. Barkauskas et al. JOURNAL OF CLINICAL INVESTIGATION
- New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
- (2013) William D. Travis et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients
- (2013) Youngwook Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer
- (2013) Sara M. Nolte et al. JNCI-Journal of the National Cancer Institute
- Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung Cancers
- (2013) Jamie E. Chaft et al. Journal of Thoracic Oncology
- Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization
- (2013) Willam Sterlacci et al. Journal of Thoracic Oncology
- Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies
- (2013) Xu-chao Zhang et al. Journal of Translational Medicine
- Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)
- (2013) Ole Raaschou-Nielsen et al. LANCET ONCOLOGY
- HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
- (2013) Madhu S. Kumar et al. NATURE
- 50-Year Trends in Smoking-Related Mortality in the United States
- (2013) Michael J. Thun et al. NEW ENGLAND JOURNAL OF MEDICINE
- 21st-Century Hazards of Smoking and Benefits of Cessation in the United States
- (2013) Prabhat Jha et al. NEW ENGLAND JOURNAL OF MEDICINE
- ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation
- (2013) F Kosari et al. ONCOGENE
- Genomics of Squamous Cell Lung Cancer
- (2013) M. Rooney et al. ONCOLOGIST
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
- (2013) Martin P. Barr et al. PLoS One
- NF-κB Regulates Mesenchymal Transition for the Induction of Non-Small Cell Lung Cancer Initiating Cells
- (2013) Manish Kumar et al. PLoS One
- Isolation of Cancer Stem Like Cells from Human Adenosquamous Carcinoma of the Lung Supports a Monoclonal Origin from a Multipotential Tissue Stem Cell
- (2013) Jennie P. Mather et al. PLoS One
- Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma
- (2013) S. Mainardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer stem cells in lung cancer: Evidence and controversies
- (2013) Muhammad Alamgeer et al. RESPIROLOGY
- The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
- (2013) Muhammad Alamgeer et al. THORAX
- MAX Inactivation in Small Cell Lung Cancer Disrupts MYC-SWI/SNF Programs and Is Synthetic Lethal with BRG1
- (2013) O. A. Romero et al. Cancer Discovery
- Morphologic and Clinicopathologic Features of Lung Squamous Cell Carcinomas ExpressingSox2
- (2012) Luka Brcic et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Measurement of Aldehyde Dehydrogenase 1 Expression Defines a Group with Better Prognosis in Patients with Non-Small Cell Lung Cancer
- (2012) Anastasios Dimou et al. AMERICAN JOURNAL OF PATHOLOGY
- Molecular and cellular biology of neuroendocrine lung tumors: Evidence for separate biological entities
- (2012) Dorian R.A. Swarts et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
- (2012) Shiwu Wu et al. BMC CANCER
- Therapeutic Effect of γ-Secretase Inhibition in KrasG12V-Driven Non-Small Cell Lung Carcinoma by Derepression of DUSP1 and Inhibition of ERK
- (2012) Antonio Maraver et al. CANCER CELL
- Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
- (2012) Ryan B. Corcoran et al. CANCER CELL
- Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446
- (2012) Xiaofei Qiu et al. CANCER LETTERS
- Mithramycin Represses Basal and Cigarette Smoke–Induced Expression ofABCG2and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
- (2012) Mary Zhang et al. CANCER RESEARCH
- Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling
- (2012) Y.-P. Liu et al. CANCER RESEARCH
- Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy
- (2012) Toshio Kubo et al. CANCER SCIENCE
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
- (2012) Ramaswamy Govindan et al. CELL
- Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
- (2012) Wen Cai Zhang et al. CELL
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
- (2012) Marcin Imielinski et al. CELL
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations
- (2012) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- Regulation of human lung alveolar multipotent cells by a novel p38α MAPK/miR-17-92 axis
- (2012) Feride Oeztuerk-Winder et al. EMBO JOURNAL
- Translating genomic information into clinical medicine: Lung cancer as a paradigm
- (2012) M. A. Levy et al. GENOME RESEARCH
- Recurrent inactivating mutations ofARID2in non-small cell lung carcinoma
- (2012) Gilles Manceau et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response
- (2012) Jaya Sangodkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
- (2012) Jian-Mei Hou et al. JOURNAL OF CLINICAL ONCOLOGY
- Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome
- (2012) Xiao Li et al. Journal of Thoracic Oncology
- Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy
- (2012) Kazuhiko Shien et al. LUNG CANCER
- EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
- (2012) Sandeep Singh et al. Molecular Cancer
- Smoking Induces Epithelial-to-Mesenchymal Transition in Non-Small Cell Lung Cancer through HDAC-Mediated Downregulation of E-Cadherin
- (2012) N. S. Nagathihalli et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
- (2012) M-J Jung et al. ONCOGENE
- The Side Population in Human Lung Cancer Cell Line NCI-H460 Is Enriched in Stem-Like Cancer Cells
- (2012) Yang Shi et al. PLoS One
- Matrix Metalloproteinase-10 Is Required for Lung Cancer Stem Cell Maintenance, Tumor Initiation and Metastatic Potential
- (2012) Verline Justilien et al. PLoS One
- Cigarette Smoke Promotes Drug Resistance and Expansion of Cancer Stem Cell-Like Side Population
- (2012) Yi An et al. PLoS One
- KIT (CD117) Expression in a Subset of Non-Small Cell Lung Carcinoma (NSCLC) Patients
- (2012) Albert D. Donnenberg et al. PLoS One
- Alveolar Type II Cells Possess the Capability of Initiating Lung Tumor Development
- (2012) Chuwen Lin et al. PLoS One
- A framework for identification of actionable cancer genome dependencies in small cell lung cancer
- (2012) M. L. Sos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma
- (2012) X. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity
- (2012) S Akunuru et al. Cell Death & Disease
- Adenosquamous Carcinoma of the Lung
- (2011) Naobumi Tochigi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung
- (2011) Kate D. Sutherland et al. CANCER CELL
- Identification of Tumorigenic Cells in KrasG12D-Induced Lung Adenocarcinoma
- (2011) H.-C. Cho et al. CANCER RESEARCH
- Notch-Dependent Differentiation of Adult Airway Basal Stem Cells
- (2011) Jason R. Rock et al. Cell Stem Cell
- Nuclear factor I/B is an oncogene in small cell lung cancer
- (2011) A. L. Dooley et al. GENES & DEVELOPMENT
- SOX2 amplification is a common event in squamous cell carcinomas of different organ sites
- (2011) Sebastian Maier et al. HUMAN PATHOLOGY
- Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium
- (2011) Eugenia C. Pacheco-Pinedo et al. JOURNAL OF CLINICAL INVESTIGATION
- SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity
- (2011) Munehide Nakatsugawa et al. LABORATORY INVESTIGATION
- Small-cell lung cancer
- (2011) Jan P van Meerbeeck et al. LANCET
- SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
- (2011) Theresia Wilbertz et al. MODERN PATHOLOGY
- A crucial requirement for Hedgehog signaling in small cell lung cancer
- (2011) Kwon-Sik Park et al. NATURE MEDICINE
- Evidence for Human Lung Stem Cells
- (2011) Jan Kajstura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rac1 Targeting Suppresses Human Non-Small Cell Lung Adenocarcinoma Cancer Stem Cell Activity
- (2011) Shailaja Akunuru et al. PLoS One
- Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
- (2011) Amit Dutt et al. PLoS One
- Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment
- (2011) Rita Mancini et al. PLoS One
- Matrix Metalloproteinase-10 Promotes Kras-Mediated Bronchio-Alveolar Stem Cell Expansion and Lung Cancer Formation
- (2011) Roderick P. Regala et al. PLoS One
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- (2011) Peter S. Hammerman et al. Cancer Discovery
- Progressive 3q Amplification Consistently TargetsSOX2in Preinvasive Squamous Lung Cancer
- (2010) Frank McCaughan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer
- (2010) C D Salcido et al. BRITISH JOURNAL OF CANCER
- Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
- (2010) J. P. Sullivan et al. CANCER RESEARCH
- Presence of a Putative Tumor-Initiating Progenitor Cell Population Predicts Poor Prognosis in Smokers with Non-Small Cell Lung Cancer
- (2010) A. T. Ooi et al. CANCER RESEARCH
- Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating Cells
- (2010) Stephen J. Curtis et al. Cell Stem Cell
- The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non-Small Cell Lung Cancer
- (2010) T. John et al. CLINICAL CANCER RESEARCH
- Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
- (2010) M. D. Wilkerson et al. CLINICAL CANCER RESEARCH
- Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases
- (2010) Yihua Sun et al. JOURNAL OF CLINICAL ONCOLOGY
- Selective activation of p53-mediated tumour suppression in high-grade tumours
- (2010) Melissa R. Junttila et al. NATURE
- Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
- (2010) Mallika Singh et al. NATURE BIOTECHNOLOGY
- Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
- (2010) Shan Deng et al. PLoS One
- Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
- (2010) Elaine Lai-Han Leung et al. PLoS One
- Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors
- (2010) J. Voortman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- (2010) J. Weiss et al. Science Translational Medicine
- Atypical Protein Kinase C Is Required for Bronchioalveolar Stem Cell Expansion and Lung Tumorigenesis
- (2009) R. P. Regala et al. CANCER RESEARCH
- A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
- (2009) V. C. Daniel et al. CANCER RESEARCH
- Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor-c-kit Autocrine Signaling Loop
- (2009) V. Levina et al. CANCER RESEARCH
- Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells
- (2009) M. Hussain et al. CANCER RESEARCH
- Achaete-Scute Complex Homologue 1 Regulates Tumor-Initiating Capacity in Human Small Cell Lung Cancer
- (2009) T. Jiang et al. CANCER RESEARCH
- The Role of Scgb1a1+ Clara Cells in the Long-Term Maintenance and Repair of Lung Airway, but Not Alveolar, Epithelium
- (2009) Emma L. Rawlins et al. Cell Stem Cell
- CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients
- (2009) Alexei V. Salnikov et al. INTERNATIONAL JOURNAL OF CANCER
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
- (2009) F. Jiang et al. MOLECULAR CANCER RESEARCH
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
- (2009) Etienne Meylan et al. NATURE
- A small-cell lung cancer genome with complex signatures of tobacco exposure
- (2009) Erin D. Pleasance et al. NATURE
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
- (2009) Adam J Bass et al. NATURE GENETICS
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Basal cells as stem cells of the mouse trachea and human airway epithelium
- (2009) J. R. Rock et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
- (2008) I. Fichtner et al. CLINICAL CANCER RESEARCH
- Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancer
- (2008) L A Frederick et al. ONCOGENE
- Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
- (2008) Vera Levina et al. PLoS One
- Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion
- (2008) J. S. Dovey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ALDH1A1 and ALDH3A1 expression in lung cancers: Correlation with histologic type and potential precursors
- (2007) Miten Patel et al. LUNG CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now